We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
31st January 2021... now how's it looking in a bruised and battered stock market, considering you can buy in at directors buy in. Plus you get to help fund a Posititve Growth company and help society.
gggg21, no probs. I’m relaxed to, some nice updates coming in June. Manufacturing increase, new products etc
This is the previous market updates of Novacyt....
Past events
Final results
14 May 2020
Final results
11 May 2020
Trading Announcement
29 April 2020
Trading Announcement
28 January 2020
Interim results
26 September 2019
AGM
18 July 2019
AGM
19 June 2019
EGM
19 June 2019
Wasn't replying to you sorry anders - was the other poster. I am relaxed, hence why I haven't been posting much. It will all come. 200m mcap quite simply still cheap. From next week we are producing 10m tests a month...…..
gggg21, I was pointing out that we won’t have to wait that long for a trading update. I pointed out that was last years update.
What you on about? What you’re looking at is dated.
AGM usually in June to so full presentation all be it via web and then sent to shareholders. Nearly June anyway and dPCR time
Thanks Anders, I was wondering about interims. I'm not up on requirements.
There is something about the share structure & listing on two markets that is nagging at me. Most companies are answerable to shareholder pressure, directors being removed by simple majority vote in UK law for example. In this one Eiffel owns 55%, other IIs 19% & small holders 26%. Eiffel has control & without having to make an offer to other shareholders as a holder of 30% would under UK law. Is this why IIs haven't build bigger stakes? Are we trapped in ways we wouldn't be in other listed companies?
I'm not deramping, just getting head round holding shares valued at £3 and falling doing such mega business.
Try2, we can expect half year trading update circa 31st July if they follow last years schedule.
Last years update here
https://www.lse.co.uk/rns/NCYT/novacyt-sa-half-year-trading-update-k4ppv79g7ftrj13.html
Quickdraw - I don't doubt demand & in my mind, this company is flying like few others, well perhaps delivering on a scale akin to the big businesses but the SP drifts down. I'd expect it to generate spectacular cash & profit but won't know that until it is required to publish its financial statements to December next April. We've got a long haul made harder if SP was much lower. Do you get what I mean?
BJ in briefing said UK have capacity for 166k tests a day, on even run rate that's 4.6m tests a month.
I guess that is right, expectations are high in this febrile atmosphere, esp mine. I have to really think harder about the job of being a shareholder - waiting with boosts from what they can disclose in terms of rdy to go, validation, & steps forward in sales & production.
Try2bylow exsig is an Rns that will be required when rdy to go and validated.
I don't think we are expecting too much as they must be aware that their last rns (which had great information) bombed. They owe it to us to put that right, and never to repeat the same mistake.
What is the requirement for an update at all?
We are all waiting for an update and guessing when it will be but what is the requirement on NCYT to make an announcement?
They announced a massive order book 4 weeks ago. I can understand them making another announcement if there were really significant increases in those orders (which I hope there are) but supposing the news is that they are working hard to deliver existing orders. I don't think there is any requirement on them to report what the revenue earned in May, or any other period of account, before their YE financial reporting requirement, is there? Of course, we'd all like to know. We'd like to know how much they sold, level of debt, cash & stock but are we expecting too much?
I'm wondering whether we'll be stuck in limbo until YE results next April in terms of what we most want to know unless an announcement of some other significant change comes along! Why couldn't that happen?
GLA!